You are viewing an incomplete version of our website. Please click to reload the website as full version.

BCL2-Like 13 (Apoptosis Facilitator) (BCL2L13) (Internal Region) Peptide

Details for Product No. ABIN1382115, Supplier: Login to see
Protein Name
  • si:ch211-238n5.7
  • Mil1
  • BCL-RAMBO
  • Bcl2-L-13
  • MIL1
  • E430016C20Rik
  • Mil-1
Protein Region
Internal Region
Origin
Human
1
Application
Blocking Peptide (BP)
Supplier
Login to see
Supplier Product No.
Login to see
Request

Showcase your results, aid the scientific community, and receive a full refund.

Contribute a validation

Learn more

Blocked Antibody anti-BCL2-Like 13 (Apoptosis Facilitator) (BCL2L13) (Middle Region) antibody (ABIN1030885)
Characteristics 15 amino acids near the center of human Bcl-rambo
Human
Application Notes Bcl-rambo peptide is used for blocking the activity of the Bcl-rambo.
Restrictions For Research Use only
Format Liquid
Concentration 200 μg/mL
Buffer PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage -20 °C
Expiry Date 12 months
Background publications Ogura, Bonen, Inohara et al.: "A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease." in: Nature, Vol. 411, Issue 6837, pp. 603-6, 2001 (PubMed).

Hugot, Chamaillard, Zouali et al.: "Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease." in: Nature, Vol. 411, Issue 6837, pp. 599-603, 2001 (PubMed).

Kataoka, Holler, Micheau et al.: "Bcl-rambo, a novel Bcl-2 homologue that induces apoptosis via its unique C-terminal extension." in: The Journal of biological chemistry, Vol. 276, Issue 22, pp. 19548-54, 2001 (PubMed).